Healthcare >> CEO Interviews >> April 9, 2001
JOHN A. O'MALLEY, PhD, has served as Chairman, President and Chief
Executive Officer of International Remote Imaging Systems, Inc. since
January 2000. From November 1998 to August 1999, he was a member of the
Office of Chief Executive. Before that Dr. O'Malley was President of
Second Opinion, a consulting firm serving the healthcare diagnostic and
biotechnology industry. Simultaneously he shared the Presidency, in
addition to being a Director and Chief Operating Officer, of Litmus
Concepts, Inc., a developer of diagnostic tests for the women's
healthcare market. He is also a director of Cytometrics, Inc., a
privately held development stage company developing non-invasive,
diagnostic instrument systems and a director of Vital Sounds, Inc., a
privately held development stage company developing a unique sensitive
stethoscope. Prior to establishing Second Opinion, he was worldwide
director of chemical manufacturing operations for the Milligen/Biosearch
Division, which Millipore Corporation acquired from New Brunswick
Scientific, where Dr. O'Malley had been its Vice President and General
Manager of the Biosearch division. Previously, he was President of
Primary Diagnostic Systems and President of Smith Kline Instruments,
both in vitro diagnostic companies. Dr. O'Malley received his BS in
Chemistry from Rutgers University and his PhD in Physical Chemistry from
the University of Pennsylvania. Profile
International Remote Imaging Systems Inc.?
Dr. O'Malley: Actually, ours is really a combination of three
businesses. We have a
